Products
Fees
Download
Promotions
Promotions
Welcome Rewards
Referral Program
US Pre-Market Options Trading
For Institutions
For Institutions
Corporate Services
Developers
Help
About
About
About Longbridge
License & Regulatory
Media Coverage
Join Us
Home
Discover
News & Info
Watchlist
Trade
LongbridgeAI
Quote List
Quote List
Huaan Hang Seng Biotech ETF
(159102.SZ)
Last Updated 00:00:00
News
Holdings
Overview
Company Encyclopedia
View More
Huaan Hang Seng Biotech ETF
159102.SZ
News
View More
Leads Biolabs' PD-L1/4-1BB Bispecific Antibody Wins Pivotal Phase III Approval, Set to Reshape the Frontline Treatment Landscape for Advanced EP-NEC
Unusual Whales
·
9 Hours ago
SZ
159615
+0.10%
SH
516500
+0.17%
SH
588250
+0.76%
Unusual Whales
·
9 Hours ago
SZ
159615
+0.10%
SH
516500
+0.17%
SH
588250
+0.76%
20:00 ETInnovent Showcased Clinical and Preclinical Results of Next-Generation Autoimmune and Ophthalmology Pipeline at the 2026 ATS and ARVO Conferences
prnewswire
·
11 Hours ago
HK
01801
-0.37%
SZ
159316
0.00%
SZ
159570
-0.07%
prnewswire
·
11 Hours ago
HK
01801
-0.37%
SZ
159316
0.00%
SZ
159570
-0.07%
Press Release: ATS: phase 2 data demonstrate the superiority of efdoralprin alfa over a standard-of-care augmentation therapy in achieving higher fAAT levels in AATD
Unusual Whales
·
Yesterday at 03:32
SH
512010
0.00%
SZ
159837
0.00%
SZ
159102
+0.27%
Unusual Whales
·
Yesterday at 03:32
SH
512010
0.00%
SZ
159837
0.00%
SZ
159102
+0.27%
RemeGen Plans Governance and Articles Overhaul Following Share Incentive Issuances
Tip Ranks
·
Yesterday at 21:42
HK
09995
-1.05%
SH
688331
+0.44%
SZ
159849
+0.21%
Tip Ranks
·
Yesterday at 21:42
HK
09995
-1.05%
SH
688331
+0.44%
SZ
159849
+0.21%
07:01 ETKali Therapeutics Announces Oral Presentation of KT502, a Novel CD19 x CD3 T-Cell Engager, at the EULAR 2026 Annual Congress
prnewswire
·
Yesterday at 19:03
SH
588250
+0.76%
US
XLV
+0.43%
US
IHE
-0.44%
prnewswire
·
Yesterday at 19:03
SH
588250
+0.76%
US
XLV
+0.43%
US
IHE
-0.44%